The analysis of a clinical database that consists of 325 gliomas cases from the CGGA dataset and 276 cases from the GSE16011 cohort showed that the expression of PIEZO1 is highly correlated with the malignancy and molecular subtypes of gliomas [63]. The gene discussed is PIEZO1; the disease is central nervous system cancer.